Aberrant astrocytes impair vascular reactivity in H untington disease

Vascular endothelial growth factor (VEGF) and its receptors

Neufeld, G., Cohen, T., Gengrinovitch, S., & Gluzman‐Poltorak, Z. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.1.9 · Cited by 3,488 · see citing works

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice

Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073 · see citing works

Huntington's disease

Walker, F. O. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60111-1 · Cited by 2,623 · see citing works

A polymorphic DNA marker genetically linked to Huntington's disease

Gusella, J. F., Wexler, N. S., Conneally, P. M., Naylor, S. L., Anderson, M. A., Tanzi, R. E., Watkins, P. C., Ottina, K. A., Wallace, M. R., Sakaguchi, A. Y., et al. (1983) · Nature · doi:10.1038/306234a0 · Cited by 2,340 · see citing works

Endothelial/Pericyte Interactions

Armulik, A., Abramsson, A., & Betsholtz, C. (2005) · Circulation Research · doi:10.1161/01.res.0000182903.16652.d7 · Cited by 2,048 · see citing works

Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice

Nitta, T., Hata, M., Gotoh, S., Seo, Y., Sasaki, H., Hashimoto, N., Furuse, M., & Tsukita, S. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302070 · Cited by 1,917 · see citing works

Huntington's disease: from molecular pathogenesis to clinical treatment

Ross, C. A., & Tabrizi, S. J. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70245-3 · Cited by 1,751 · see citing works

Uniquely Hominid Features of Adult Human Astrocytes

Oberheim, N. A., Takano, T., Han, X., He, W., Lin, J. H. C., Wang, F., Xu, Q., Wyatt, J. D., Pilcher, W., Ojemann, J. G., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4707-08.2009 · Cited by 1,488 · see citing works

Pericytes Control Key Neurovascular Functions and Neuronal Phenotype in the Adult Brain and during Brain Aging

Bell, R. D., Winkler, E. A., Sagare, A. P., Singh, I., LaRue, B., Deane, R., & Zlokovic, B. V. (2010) · Neuron · doi:10.1016/j.neuron.2010.09.043 · Cited by 1,448 · see citing works

Bidirectional control of CNS capillary diameter by pericytes

Peppiatt, C. M., Howarth, C., Mobbs, P., & Attwell, D. (2006) · Nature · doi:10.1038/nature05193 · Cited by 1,150 · see citing works

Central nervous system pericytes in health and disease

Winkler, E. A., Bell, R. D., & Zlokovic, B. V. (2011) · Nature Neuroscience · doi:10.1038/nn.2946 · Cited by 962 · see citing works

Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin [published erratum appears in Hum Mol Genet 1999 May;8(5):943]

Schilling, G. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.3.397 · Cited by 755 · see citing works

Review: Cerebral microvascular pathology in ageing and neurodegeneration

Brown, W. R., & Thore, C. R. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01139.x · Cited by 749 · see citing works

Astrocyte–neuron metabolic relationships: for better and for worse

Allaman, I., Bélanger, M., & Magistretti, P. J. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2010.12.001 · Cited by 639 · see citing works

Severely impaired cerebrovascular reactivity predicts stroke and TIA risk in patients with carotid artery stenosis and occlusion

Markus, H. S. (2001) · Brain · doi:10.1093/brain/124.3.457 · Cited by 541 · see citing works

Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms

Bradford, J. W., Shin, J., Redd, M. A., Wang, C.-E., Li, X.-J., & Li, S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911503106 · Cited by 362 · see citing works

Vascular basis for brain degeneration: faltering controls and risk factors for dementia

Kalaria, R. N. (2010) · Nutrition Reviews · doi:10.1111/j.1753-4887.2010.00352.x · Cited by 291 · see citing works

Cerebrovascular Reactivity and Cognitive Decline in Patients With Alzheimer Disease

Silvestrini, M., Pasqualetti, P., Baruffaldi, R., Bartolini, M., Handouk, Y., Matteis, M., Moffa, F., Provinciali, L., & Vernieri, F. (2006) · Stroke · doi:10.1161/01.str.0000206439.62025.97 · Cited by 278 · see citing works

A critical role of astrocyte-mediated nuclear factor-κB-dependent inflammation in Huntington's disease

Hsiao, H., Chen, Y., Chen, H., Tu, P., & Chern, Y. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt036 · Cited by 241 · see citing works

Blood–Spinal Cord Barrier Pericyte Reductions Contribute to Increased Capillary Permeability

Winkler, E. A., Sengillo, J. D., Bell, R. D., Wang, J., & Zlokovic, B. V. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.113 · Cited by 226 · see citing works

Evaluation of Cerebral Vasomotor Reactivity by Various Vasodilating Stimuli: Comparison of CO 2 to Acetazolamide

Ringelstein, E. B., Eyck, S. V., & Mertens, I. (1992) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1992.20 · Cited by 225 · see citing works

Activation of the IκB Kinase Complex and Nuclear Factor-κB Contributes to Mutant Huntingtin Neurotoxicity

Khoshnan, A., Ko, J., Watkin, E. E., Paige, L. A., Reinhart, P. H., & Patterson, P. H. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.2675-04.2004 · Cited by 222 · see citing works

The CNS microvascular pericyte: pericyte-astrocyte crosstalk in the regulation of tissue survival

Bonkowski, D., Katyshev, V., Balabanov, R. D., Borisov, A., & Dore-Duffy, P. (2011) · Fluids and Barriers of the CNS · doi:10.1186/2045-8118-8-8 · Cited by 207 · see citing works

Impaired cerebral vasoreactivity to CO2 in Alzheimer's disease using BOLD fMRI

Cantin, S., Villien, M., Moreaud, O., Troprés, I., Keignart, S., Chipon, E., Bas, J. F. L., Warnking, J. M., & Krainik, A. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.06.070 · Cited by 161 · see citing works

Reduced basal ganglia blood flow and volume in pre-symptomatic, gene-tested persons at-risk for Huntington's disease

Harris, G. J., Codori, A. M., Lewis, R. F., Schmidt, E. U., Bedi, A., & Brandt, J. (1999) · Brain · doi:10.1093/brain/122.9.1667 · Cited by 142 · see citing works

Inhibition of soluble tumor necrosis factor is therapeutic in Huntington's disease

Hsiao, H., Chiu, F., Chen, C., Wu, Y., Chen, H., Chen, Y., Kuo, H., & Chern, Y. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu151 · Cited by 135 · see citing works

Nonnvasive assessment of vascular architecture and function during modulated blood oxygenation using susceptibility weighted magnetic resonance imaging

Rauscher, A., Sedlacik, J., Barth, M., Haacke, E. M., & Reichenbach, J. R. (2005) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20520 · Cited by 132 · see citing works

Age-dependent neurovascular abnormalities and altered microglial morphology in the YAC128 mouse model of Huntington disease

Franciosi, S., Ryu, J. K., Shim, Y. A., Hill, A. M., Connolly, C., Hayden, M. R., McLarnon, J. G., & Leavitt, B. R. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.09.003 · Cited by 124 · see citing works

Expanded-Polyglutamine Huntingtin Protein Suppresses the Secretion and Production of a Chemokine (CCL5/RANTES) by Astrocytes

Chou, S., Weng, J.-Y., Lai, H., Liao, F., Sun, S. H., Tu, P., Dickson, D. W., & Chern, Y. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0116-08.2008 · Cited by 115 · see citing works

A novel and simple method for culturing pericytes from mouse brain

Tigges, U., Welser-Alves, J. V., Boroujerdi, A., & Milner, R. (2012) · Microvascular Research · doi:10.1016/j.mvr.2012.03.008 · Cited by 110 · see citing works

CONNEXIN EXPRESSION IN HUNTINGTON'S DISEASED HUMAN BRAIN

Vis, J. C., Nicholson, L. F. B., Faull, R. L. M., Evans, W. H., Severs, N. J., & Green, C. R. (1998) · Cell Biology International · doi:10.1006/cbir.1998.0388 · Cited by 102 · see citing works

Neurovascular abnormalities in humans and mice with Huntington's disease

Lin, C.-Y., Hsu, Y.-H., Lin, M.-H., Yang, T.-H., Chen, H.-M., Chen, Y.-C., Hsiao, H.-Y., Chen, C.-C., Chern, Y., & Chang, C. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.08.019 · Cited by 98 · see citing works

Mapping of cerebrovascular reactivity using bold magnetic resonance imaging

Lythgoe, D. J., Williams, S., Cullinane, M., & Markus, H. S. (1999) · Magnetic Resonance Imaging · doi:10.1016/s0730-725x(98)00211-2 · Cited by 80 · see citing works

R6/2 Huntington's Disease Mice Develop Early and Progressive Abnormal Brain Metabolism and Seizures

Cepeda-Prado, E., Popp, S., Khan, U., Stefanov, D. G., Rodríguez, J., Menalled, L., Dow-Edwards, D. L., Small, S. A., & Moreno, H. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0388-12.2012 · Cited by 79 · see citing works

Heme Oxygenase-1/Carbon Monoxide Induces Vascular Endothelial Growth Factor Expression via p38 Kinase-dependent Activation of Sp1

Lin, H., Lai, S.-C., & Chau, L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.168831 · Cited by 73 · see citing works

Complex relationships between cerebral blood flow and brain atrophy in early Huntington's disease

Chen, J. J., Salat, D. H., & Rosas, H. D. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.08.112 · Cited by 70 · see citing works

Isolation and culture of endothelial cells, pericytes and perivascular resident macrophage-like melanocytes from the young mouse ear

Neng, L., Zhang, W., Hassan, A. M., Zemla, M., Kachelmeier, A., Fridberger, A., Auer, M., & Shi, X. (2013) · Nature Protocols · doi:10.1038/nprot.2013.033 · Cited by 69 · see citing works

Investigation of the influence of carbon dioxide concentrations on cerebral physiology by susceptibility-weighted magnetic resonance imaging (SWI)

Sedlacik, J., Kutschbach, C., Rauscher, A., Deistung, A., & Reichenbach, J. R. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.07.008 · Cited by 63 · see citing works

Magnetic resonance perfusion imaging of resting-state cerebral blood flow in preclinical Huntington's disease

Wolf, R. C., Grön, G., Sambataro, F., Vasić, N., Wolf, N. D., Thomann, P. A., Carsten Saft, C., Landwehrmeyer, G. B., & Orth, M. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.60 · Cited by 62 · see citing works

Increased Prothrombin, Apolipoprotein A-IV, and Haptoglobin in the Cerebrospinal Fluid of Patients with Huntington's Disease

Huang, Y.-C., Wu, Y., Tseng, M., Chen, Y., Hsieh, S., & Chen, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015809 · Cited by 61 · see citing works

Elevated arteriolar cerebral blood volume in prodromal Huntington's disease

Hua, J., Unschuld, P. G., Margolis, R. L., van Zijl, P. C. M., & Ross, C. A. (2013) · Movement Disorders · doi:10.1002/mds.25591 · Cited by 54 · see citing works

In vivo cerebromicrovasculatural visualization using 3D ΔR2-based microscopy of magnetic resonance angiography (3DΔR2-mMRA)

Lin, C.-Y. E., Lin, M.-H., Cheung, W., Lin, T., Chen, J., & Chang, C. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.12.030 · Cited by 38 · see citing works

Amyloid-β25–35, an Amyloid-β1–42 Surrogate, and Proinflammatory Cytokines Stimulate VEGF-A Secretion by Cultured, Early Passage, Normoxic Adult Human Cerebral Astrocytes

Chiarini, A., Whitfield, J., Bonafini, C., Chakravarthy, B., Armato, U., & Prà, I. D. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100471 · Cited by 35 · see citing works

Neurovascular abnormalities in brain disorders: highlights with angiogenesis and magnetic resonance imaging studies

Chen, C.-C. V., Chen, Y., Hsiao, H., Chang, C., & Chern, Y. (2013) · Journal of Biomedical Science · doi:10.1186/1423-0127-20-47 · Cited by 31 · see citing works

In VivoEvidence of Increased nNOS Activity in Acute MPTP Neurotoxicity: A Functional Pharmacological MRI Study

Siow, T. Y., Chen, C.-C. V., Wan, N., Chow, K.-P. N., & Chang, C. (2013) · BioMed Research International · doi:10.1155/2013/964034 · Cited by 8 · see citing works

Blood-Brain Barrier: From Physiology to Disease and Back

Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,294 · see citing works

Astrocytes: a central element in neurological diseases

Pekny, M., Pekna, M., Messing, A., Steinhäuser, C., Lee, J., Parpura, V., Hol, E. M., Sofroniew, M. V., & Verkhratsky, A. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1513-1 · Cited by 755 · see citing works

The blood-brain barrier in aging and neurodegeneration

Knox, E. G., Aburto, M. R., Clarke, G., Cryan, J. F., & O’Driscoll, C. M. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01511-z · Cited by 738 · see citing works

Brain Energy and Oxygen Metabolism: Emerging Role in Normal Function and Disease

Watts, M. E., Pocock, R., & Claudianos, C. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00216 · Cited by 414 · see citing works

Targeting pericytes for therapeutic approaches to neurological disorders

Cheng, J., Korte, N., Nortley, R., Sethi, H., Tang, Y., & Attwell, D. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1893-0 · Cited by 242 · see citing works

Huntington’s Disease iPSC-Derived Brain Microvascular Endothelial Cells Reveal WNT-Mediated Angiogenic and Blood-Brain Barrier Deficits

Lim, R. G., Quan, C., Reyes-Ortiz, A. M., Lutz, S. E., Kedaigle, A. J., Gipson, T. A., Wu, J., Vatine, G. D., Stocksdale, J., Casale, M. S., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.04.021 · Cited by 253 · see citing works

The Role of Microglia and Astrocytes in Huntington’s Disease

Palpagama, T. H., Waldvogel, H. J., Faull, R. L. M., & Kwakowsky, A. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00258 · Cited by 241 · see citing works

Stratification of astrocytes in healthy and diseased brain

Verkhratsky, A., Zorec, R., & Parpura, V. (2017) · Brain Pathology · doi:10.1111/bpa.12537 · Cited by 236 · see citing works

Diversity of astroglial responses across human neurodegenerative disorders and brain aging

Ferrer, I. (2017) · Brain Pathology · doi:10.1111/bpa.12538 · Cited by 123 · see citing works

Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models

Logan, S., Arzua, T., Canfield, S. G., Seminary, E. R., Sison, S. L., Ebert, A. D., & Bai, X. (2019) · Comprehensive physiology · doi:10.1002/cphy.c180025 · Cited by 139 · see citing works

Translational potential of astrocytes in brain disorders

Verkhratsky, A., Steardo, L., Parpura, V., & Montana, V. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.003 · Cited by 110 · see citing works

Astrocyte and Alzheimer’s disease

Cai, Z.-Y., Wan, C., & Liu, Z. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8593-x · Cited by 96 · see citing works

Impairment of blood-brain barrier is an early event in R6/2 mouse model of Huntington Disease

Pardo, A. D., Amico, E., Scalabrì, F., Pepe, G., Castaldo, S., Elifani, F., Capocci, L., Sanctis, C. D., Comerci, L., Pompeo, F., et al. (2017) · Scientific Reports · doi:10.1038/srep41316 · Cited by 99 · see citing works

The Role of Neurovascular System in Neurodegenerative Diseases

Ahmad, A., Patel, V., Xiao, J., & Khan, M. M. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02023-z · Cited by 94 · see citing works

Blood–Brain Barrier and Neurodegenerative Diseases—Modeling with iPSC-Derived Brain Cells

Wu, Y., Sonninen, T.-M., Peltonen, S., Koıstınaho, J., & Lehtonen, Š. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147710 · Cited by 88 · see citing works

From Neurodevelopmental to Neurodegenerative Disorders: The Vascular Continuum

Ouellette, J., & Lacoste, B. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.749026 · Cited by 87 · see citing works

Blood–brain barrier endothelial cells in neurodegenerative diseases: Signals from the “barrier”

Yuan, Y., Sun, J., Dong, Q., & Cui, M. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1047778 · Cited by 86 · see citing works

Cerebrovascular plasticity: Processes that lead to changes in the architecture of brain microvessels

Bogorad, M. I., DeStefano, J. G., Linville, R. M., Wong, A. D., & Searson, P. C. (2019) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x19855875 · Cited by 72 · see citing works

Reactive astrocytes promote proteostasis in Huntington’s disease through the JAK2-STAT3 pathway

Abjean, L., Haim, L. B., Riquelme‐Perez, M., Gipchtein, P., Derbois, C., Palomares, M.-A., Petit, F., Hérard, A., Gaillard, M., Guillermier, M., et al. (2022) · Brain · doi:10.1093/brain/awac068 · Cited by 72 · see citing works

Laquinimod rescues striatal, cortical and white matter pathology and results in modest behavioural improvements in the YAC128 model of Huntington disease

Garcia‐Miralles, M., Hong, X., Tan, L. J., Caron, N. S., Huang, Y., To, X. V., Lin, R. Y., Franciosi, S., Papapetropoulos, S., Hayardeny, L., et al. (2016) · Scientific Reports · doi:10.1038/srep31652 · Cited by 66 · see citing works

Cerebellar degeneration correlates with motor symptoms in Huntington disease

Singh‐Bains, M. K., Mehrabi, N. F., Sehji, T., Austria, M. D. R., Tan, A. Y. S., Tippett, L. J., Dragunow, M., Waldvogel, H. J., & Faull, R. L. M. (2019) · Annals of Neurology · doi:10.1002/ana.25413 · Cited by 61 · see citing works

From Neuronal Differentiation of iPSCs to 3D Neuro-Organoids: Modelling and Therapy of Neurodegenerative Diseases

Bordoni, M., Rey, F., Fantini, V., Pansarasa, O., Giulio, A. M. D., Carelli, S., & Cereda, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123972 · Cited by 59 · see citing works

Mortal engines: Mitochondrial bioenergetics and dysfunction in neurodegenerative diseases

Joshi, A. U., & Mochly‐Rosen, D. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.08.010 · Cited by 57 · see citing works

Digital Reconstruction of the Neuro-Glia-Vascular Architecture

Zisis, E., Keller, D. X., Kanari, L., Arnaudon, A., Gevaert, M., Delemontex, T., Coste, B., Foni, A., Abdellah, M., Calì, C., et al. (2021) · Cerebral Cortex · doi:10.1093/cercor/bhab254 · Cited by 53 · see citing works

Astrocyte structural reactivity and plasticity in models of retinal detachment

Luna, G., Keeley, P. W., Reese, B. E., Linberg, K. A., Lewis, G. P., & Fisher, S. K. (2016) · Experimental Eye Research · doi:10.1016/j.exer.2016.03.027 · Cited by 53 · see citing works

Platelet abnormalities in Huntington’s disease

Denis, H. L., Lamontagne‐Proulx, J., St‐Amour, I., Mason, S., Rowley, J. W., Cloutier, N., Tremblay, M., Vincent, A. T., Gould, P. V., Chouinard, S., et al. (2018) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2018-318854 · Cited by 47 · see citing works

The Role of Adenosine Tone and Adenosine Receptors in Huntington's Disease

Blum, D. L., Chern, Y., Domenici, M. R., Buée, L., Lin, C., Rea, W. P., Ferré, S., & Popoli, P. (2018) · Journal of Caffeine and Adenosine Research · doi:10.1089/caff.2018.0006 · Cited by 45 · see citing works

Dysregulated Brain Cholesterol Metabolism Is Linked to Neuroinflammation in Huntington's Disease

González‐Guevara, E., Cárdenas, G., Pérez‐Severiano, F., & Martínez‐Lazcano, J. C. (2020) · Movement Disorders · doi:10.1002/mds.28089 · Cited by 43 · see citing works

Astrocytes: The Stars in Neurodegeneration?

Dittlau, K. S., & Freude, K. (2024) · Biomolecules · doi:10.3390/biom14030289 · Cited by 38 · see citing works

Induced Pluripotent Stem Cells in Huntington’s Disease Research: Progress and Opportunity

Tousley, A. R., & Kegel-Gleason, K. B. (2016) · Journal of Huntington s Disease · doi:10.3233/jhd-160199 · Cited by 37 · see citing works

Astrocytes in Neuropathologies Affecting the Frontal Cortex

Peteri, U., Niukkanen, M., & Castrén, M. L. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00044 · Cited by 36 · see citing works

Cerebral vasomotor reactivity in neurodegenerative diseases

Smoliński, Ł., & Członkowska, A. (2016) · Neurologia i Neurochirurgia Polska · doi:10.1016/j.pjnns.2016.07.011 · Cited by 35 · see citing works

Representing Diversity in the Dish: Using Patient-Derived in Vitro Models to Recreate the Heterogeneity of Neurological Disease

Ghaffari, L., Starr, A., Nelson, A. T., & Sattler, R. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00056 · Cited by 34 · see citing works

Brain pericyte activation occurs early in Huntington's disease

Padel, T., Roth, M., Gaceb, A., Li, J., Björkqvist, M., & Paul, G. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.03.015 · Cited by 34 · see citing works

Astrocytes: From the Physiology to the Disease

Trujillo‐Estrada, L., Gómez-Arboledas, Á., Forner, S., Martini, A. C., Gutiérrez, A., Baglietto‐Vargas, D., & LaFerla, F. M. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190830110152 · Cited by 30 · see citing works

Phenotypic heterogeneity of astrocytes in motor neuron disease

Trías, E., Barbeito, L., & Yamanaka, K. (2018) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12476 · Cited by 31 · see citing works

Single-nuclei transcriptome analysis of Huntington disease iPSC and mouse astrocytes implicates maturation and functional deficits

Reyes-Ortiz, A. M., Abud, E. M., Burns, M. S., Wu, J., Hernandez, S. J., McClure, N. R., Wang, K. Q., Schulz, C. J., Miramontes, R., Lau, A., et al. (2022) · iScience · doi:10.1016/j.isci.2022.105732 · Cited by 28 · see citing works

The therapeutic potential of probucol and probucol analogues in neurodegenerative diseases

Sharif, A., Mamo, J. C. L., Lam, V., Al‐Salami, H., Mooranian, A., Watts, G. F., Clarnette, R., Luna, G., & Takechi, R. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00398-w · Cited by 29 · see citing works

Brain microvascular endothelial cell dysfunction in an isogenic juvenile iPSC model of Huntington’s disease

Linville, R. M., Nerenberg, R. F., Grifno, G. N., Arevalo, D., Guo, Z., & Searson, P. C. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00347-7 · Cited by 27 · see citing works

Systemic Symptoms in Huntington's Disease: A Comprehensive Review

Mehanna, R., & Jankovic, J. J. (2024) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.14029 · Cited by 25 · see citing works

Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models

Logan, S., Arzua, T., Canfield, S. G., Seminary, E. R., Sison, S. L., Ebert, A. D., & Bai, X. (2019) · Comprehensive physiology · doi:10.1002/j.2040-4603.2019.tb00076.x · Cited by 24 · see citing works

Modelling the Human Blood–Brain Barrier in Huntington Disease

Vignone, D., Paz, O. G., Fini, I., Cellucci, A., Auciello, G., Battista, M. R., Gloaguen, I., Fortuni, S., Cariulo, C., Khetarpal, V. K., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147813 · Cited by 24 · see citing works

Hypertension, Antihypertensive Use and the Delayed‐Onset of Huntington's Disease

Steventon, J. J., Rosser, A., Hart, E. C., & Murphy, K. (2020) · Movement Disorders · doi:10.1002/mds.27976 · Cited by 24 · see citing works

Vascular endothelial growth factor increases the function of calcium‐impermeable AMPA receptor GluA2 subunit in astrocytes via activation of protein kinase C signaling pathway

Kou, Z., Mo, J., Wu, K., Qiu, M., Huang, Y., Tao, F., Yu, L., Lv, L., & Sun, F. (2019) · Glia · doi:10.1002/glia.23609 · Cited by 22 · see citing works

Neurological diseases at the blood-brain barrier: Stemming new scientific paradigms using patient-derived induced pluripotent cells

Page, S., Patel, R., Raut, S., & Al-Ahmad, A. J. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.12.009 · Cited by 22 · see citing works

Neural In Vitro Models for Studying Substances Acting on the Central Nervous System

Fritsche, E., Tigges, J., Hartmann, J., Kapr, J., Serafini, M. M., & Viviani, B. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2020_367 · Cited by 20 · see citing works

Peroxisome Proliferator-Activated Receptor γ Coactivator 1α Activates Vascular Endothelial Growth Factor That Protects Against Neuronal Cell Death Following Status Epilepticus through PI3K/AKT and MEK/ERK Signaling

Huang, J.-B., Hsu, S., Pan, H.-Y., Chen, S., Chen, S., Lin, T., Liu, X.-P., Li, J.-H., Chen, N.-C., Liou, C., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197247 · Cited by 20 · see citing works

Mutant huntingtin protein expression and blood–spinal cord barrier dysfunction in huntington disease

Sciacca, G., & Cicchetti, F. (2017) · Annals of Neurology · doi:10.1002/ana.25107 · Cited by 20 · see citing works

Connectomic imaging reveals Huntington‐related pathological and pharmaceutical effects in a mouse model

Chang, W., Puspitasari, F., Garcia‐Miralles, M., Yeow, L. Y., Tay, H. C., Koh, K. B., Tan, L. J., Pouladi, M. A., & Chuang, K. (2018) · NMR in Biomedicine · doi:10.1002/nbm.4007 · Cited by 19 · see citing works

Three-dimensional remodeling of functional cerebrovascular architecture and gliovascular unit in leptin receptor-deficient mice

Liu, Y., Chen, D., Smith, A., Ye, Q., Gao, Y., & Zhang, W. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x211006596 · Cited by 18 · see citing works

Impaired Cerebrovascular Reactivity in Huntington’s Disease

Chan, S., Mercaldo, N. D., Kwong, K. K., Hersch, S. M., & Rosas, H. D. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.663898 · Cited by 18 · see citing works

Gut dysbiosis and homocysteine: a couple for boosting neurotoxicity in Huntington disease

Martínez‐Lazcano, J. C., González‐Guevara, E., Boll, M., & Cárdenas, G. (2022) · Reviews in the Neurosciences · doi:10.1515/revneuro-2021-0164 · Cited by 16 · see citing works

Revolutionizing Ischemic Stroke Diagnosis and Treatment: The Promising Role of Neurovascular Unit-Derived Extracellular Vesicles

Gao, X., Liu, D., Yue, K., Zhang, Z., Jiang, X., & Luo, P. (2024) · Biomolecules · doi:10.3390/biom14030378 · Cited by 17 · see citing works

Mouse models of neurodegenerative disease: preclinical imaging and neurovascular component

Albanese, S., Greco, A., Auletta, L., & Mancini, M. (2018) · Brain Imaging and Behavior · doi:10.1007/s11682-017-9770-3 · Cited by 16 · see citing works

Endothelial Dysfunction in Huntington’s Disease: Pathophysiology and Therapeutic Implications

Hu, N., Chen, Z., Zhao, X., Peng, X., Wu, Y. S., Yang, K., & Sun, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041432 · Cited by 15 · see citing works

Regulation of P-glycoprotein expression in brain capillaries in Huntington’s disease and its impact on brain availability of antipsychotic agents risperidone and paliperidone

Kao, Y.-H., Chern, Y., Yang, H., Chen, H., & Lin, C. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15606459 · Cited by 15 · see citing works

An altered extracellular matrix–integrin interface contributes to Huntington’s disease-associated CNS dysfunction in glial and vascular cells

Hernandez, S. J., Lim, R. G., Onur, T. S., Dane, M. A., Smith, R. L., Wang, K. Q., Jean, G. E., Reyes-Ortiz, A. M., Devlin, K. L., Miramontes, R., et al. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac303 · Cited by 13 · see citing works

The contribution of preclinical magnetic resonance imaging and spectroscopy to Huntington’s disease

Pérot, J., Brouillet, E., & Flament, J. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1306312 · Cited by 12 · see citing works

Irisin Attenuates Pathological Neovascularization in Oxygen-Induced Retinopathy Mice

Zhang, J., Liu, Z., Wu, H., Chen, X., Hu, Q., Li, X., Luo, L., Ye, S., & Ye, J. (2022) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.63.6.21 · Cited by 12 · see citing works

Neuroprotection beyond neurons: integrated biomarker-based and astroglia- or microglia-targeted approaches to combat neurodegenerative diseases

Volonté, C., Hu, G., Shaw, C. A., Claudio, V. J., dos Santos, J. A., Vaz, S. H., Sebastião, A. M., Balcar, V. J., Mozley, P. D., Verde, F., et al. (2026) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2026.1004136 · Cited by 12 · see citing works

Role of Basal Forebrain Neurons in Adrenomyeloneuropathy in Mice and Humans

Gong, Y., Laheji, F., Berenson, A., Li, Y., Moser, A., Qian, A., Frosch, M., Sadjadi, R., Hahn, R., Maguire, C. A., et al. (2024) · Annals of Neurology · doi:10.1002/ana.26849 · Cited by 11 · see citing works

Involvement of an Aberrant Vascular System in Neurodevelopmental, Neuropsychiatric, and Neuro-Degenerative Diseases

Ishihara, K., Takata, K., & Mizutani, K. (2023) · Life · doi:10.3390/life13010221 · Cited by 10 · see citing works

Altered cerebrovascular response to acute exercise in patients with Huntington’s disease

Steventon, J. J., Furby, H., Ralph, J., O’Callaghan, P., Rosser, A., Wise, R. G., Busse, M. E., & Murphy, K. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa044 · Cited by 10 · see citing works

Longitudinal alterations in brain perfusion and vascular reactivity in the zQ175DN mouse model of Huntington’s disease

Vasilkovska, T., Salajeghe, S., Vanreusel, V., Audekerke, J. V., Verschuuren, M., Hirschler, L., Warnking, J. M., Pintelon, I., Pustina, D., Cachope, R., et al. (2024) · Journal of Biomedical Science · doi:10.1186/s12929-024-01028-3 · Cited by 8 · see citing works

EGF Treatment Improves Motor Behavior and Cortical GABAergic Function in the R6/2 Mouse Model of Huntington’s Disease

Marottoli, F. M., Priego, M., Flores-Barrera, E., Pisharody, R., Zaldua, S., Fan, K. D., Ekkurthi, G. K., Brady, S. T., Morfini, G. A., Tseng, K. Y., et al. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1634-y · Cited by 8 · see citing works

Reactive astrocytes promote proteostasis in Huntington’s disease through the JAK2-STAT3 pathwayPreprint

Abjean, L., Haim, L. B., Riquelme‐Perez, M., Gipchtein, P., Derbois, C., Palomares, M.-A., Petit, F., Hérard, A., Gaillard, M., Guillermier, M., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.29.441924 · Cited by 8 · see citing works

Disrupted vasculature and blood–brain barrier in H untington disease

Waldvogel, H. J., Dragunow, M., & Faull, R. L. M. (2015) · Annals of Neurology · doi:10.1002/ana.24445 · Cited by 7 · see citing works

Role of dysregulated calcium homeostasis in astrocytes in neurodegenerative disorders

Sanchez-Mico, M. V., Calvo-Rodríguez, M., & Bacskai, B. J. (2026) · Nature reviews. Neuroscience · doi:10.1038/s41583-026-01032-6 · Cited by 6 · see citing works

Evolution of aberrant brain‐wide spatiotemporal dynamics of resting‐state networks in a Huntington's disease mouse model

Vasilkovska, T., Verschuuren, M., Pustina, D., van den Berg, M., Audekerke, J. V., Pintelon, I., Cachope, R., Vos, W. H. D., der Linden, A. V., Adhikari, M. H., et al. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.70055 · Cited by 6 · see citing works

From Neuronal Differentiation of iPSCs to 3D Neural Organoids: Modeling of Neurodegenerative Diseases

Bordoni, M., Fantini, V., Pansarasa, O., & Cereda, C. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.80055 · Cited by 6 · see citing works

Elucidating cortical neurovascular involvement in Huntington's disease using human brain tissue microarrays

Tan, A. Y. S., Martinez, L. C. M. G., Murray, H. C., Mehrabi, N. F., Tippett, L. J., Turner, C. P., Curtis, M. A., Faull, R. L. M., Dragunow, M., & Singh‐Bains, M. K. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106829 · Cited by 5 · see citing works

Targeting cerebrovascular impairments in Huntington's disease: a novel treatment perspective.

St-Amour, I., Aubé, B., Rieux, M., & Cicchetti, F. (2015) · Neurodegenerative Disease Management · doi:10.2217/nmt.15.41 · Cited by 5 · see citing works

Astrocyte-neuron combined targeting for CYP46A1 gene therapy in Huntington’s disease

Parsai, L.-H., Chali, F., Subashi, E., Zeitouny, C., Rey, E., Berniard, A., Bitton, W., Urli, L., Rousselot, L., Sarrazin, N., et al. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-02054-4 · Cited by 4 · see citing works

What Is the Role of Adenosine Tone and Adenosine Receptors in Huntington’s Disease?

Blum, D. L., Chern, E. C., Domenici, M. R., Buée, L., Lin, C. Y., Ferré, S., & Popoli, P. (2018) · Springer eBooks · doi:10.1007/978-3-319-90808-3_12 · Cited by 3 · see citing works

Aptamer Detection of Neurodegenerative Disease Biomarkers

Xi, H., & Zhang, Y. (2021) · Neuromethods · doi:10.1007/978-1-0716-1712-0_15 · Cited by 3 · see citing works

New evidence of vascular defects in neurodegenerative diseases revealed by single cell RNA sequencing

Qiu, J., Peng, S., Qu, R., Wu, L., Xing, L., Zhang, L., & Sun, J. (2024) · Clinical Science · doi:10.1042/cs20241658 · Cited by 3 · see citing works

The roles of microglia and astrocytes in inflammasomes and neurological disorders

Xia, Y., Huang, Y., Liu, Y., Zhang, X., Kang, H., Liu, Y., Yu, C., Gan, C., & Zhang, H. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01574 · Cited by 2 · see citing works

Induced pluripotent stem cells from a transgenic minipig model of Huntington's disease reveal early metabolic changes

Ryšánková, I., Sekáč, D., Hansíková, H., Kepková, K. V., Vodička, P., Vaškovičová, M., Altmanová, M., Juhás, Š., Juhásová, J., Táborská, E., et al. (2026) · Disease Models & Mechanisms · doi:10.1242/dmm.052585 · Cited by 2 · see citing works

Central nervous system diseases associated with blood brain barrier breakdown - A Comprehensive update of existing literature

Dutta, R. (2020) · Journal of Neuroscience and Neurological Disorders · doi:10.29328/journal.jnnd.1001035 · Cited by 2 · see citing works

Blood-brain barrier integrity and prevalence of intrathecal T helper 17.1 cells in Huntington´s disease

Ásbjörnsdóttir, B., Musaeus, C. S., Hellem, M. N. N., Vinther‐Jensen, T., Ejlerskov, P., Budtz–Jørgensen, E., Qvist, F. L., Simonsen, A. H., Hjermind, L. E., Skotte, N. H., et al. (2026) · PLoS ONE · doi:10.1371/journal.pone.0340683 · Cited by 1 · see citing works

Friend or foe? Glial–vascular interactions in health and neurodegenerative disease

McQuaid, C., Sewell, M. D. E., & Montagne, A. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100143 · Cited by 1 · see citing works

The development of cerebral vasculature and related diseases

Ma, J., Min, X., Wu, M., & Zhang, J. (2023) · Scientia Sinica Vitae · doi:10.1360/ssv-2023-0092 · Cited by 1 · see citing works

Integrated transcriptome analysis of Huntington’s disease iPSC-derived and mouse astrocytes implicates dysregulated synaptogenesis, actin, and astrocyte maturationPreprint

Reyes-Ortiz, A. M., Abud, E. M., Burns, M. S., Wu, J., Hernandez, S. J., Geller, N. R., Wang, K. Q., Schulz, C. J., Miramontes, R., Lau, A., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.28.501170 · Cited by 1 · see citing works

Vascular dysfunction in Huntington’s disease is located at the blood-CSF barrier and is rescued by sphingosine-1-phosphate receptor agonistPreprint

Kucharz, K., Soylu-Kucharz, R., Saint‐Pierre, M., Alpaugh, M., Qvist, F. L., Björkqvist, M., Skotte, N. H., Cicchetti, F., & Lauritzen, M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.30.650996 · Cited by 1 · see citing works

Pathophysiology of the Blood–Brain Barrier in Neuroinflammatory Diseases

Majerová, P., & Kováč, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-45514-3_4

‘Non-self’ mutation in a Drosophila model of expanded CAG repeat neurodegenerative disease

Scott, A. W. (2019) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)

Post-stroke dizziness of visual-vestibular cortices origin

Inoue, N., & Goto, S. (2020) · Journal of Neuroscience and Neurological Disorders · doi:10.29328/journal.jnnd.1001038

Activation of Astrocytes in Neurodegenerative Diseases

Li, J., & Qin, S. (2021) · Neuromethods · doi:10.1007/978-1-0716-1712-0_3

The Role of Glia in Huntington’s Disease

Joshi, T., & Jana, N. R. (2022) · Springer eBooks · doi:10.1007/978-981-16-8313-8_24

Functional and Physiological MRI Measures as Early Biomarkers for Huntington’s Disease

Duan, W. (2023) · Contemporary clinical neuroscience · doi:10.1007/978-3-031-32815-2_7

Additional file 2 of Brain microvascular endothelial cell dysfunction in an isogenic juvenile iPSC model of Huntington’s disease

Linville, R. M., Nerenberg, R. F., Grifno, G. N., Arevalo, D., Guo, Z., & Searson, P. C. (2022) · Figshare · doi:10.6084/m9.figshare.20208314

Mesenchymal Stromal Cell Therapeutic Potential to Restore Neurovascular Integrity in Machado-Joseph DiseasePreprint

Barros, I., Gonzaga, D., Lobo, D., Lopes, S., Martins, I. M., Silva, A., Silva, C. H., Gomes, C. M. F., Nobre, R. J., de Almeida, L. P., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.31.703043

Les astrocytes réactifs, des partenaires anti-agrégants dans la maladie de Huntington : identification des mécanismes impliqués dans le dialogue neurone-astrocyte

Abjean, L. (2019) · theses.fr (ABES) · doi:10.70675/f664e003zf93fz467eza6a3z3d953eaffe4e

Study of vesicular glycolysis in health and Huntington's Disease

Cluskey, M. M. (2021) · doi:10.70675/eb022640z9c3cz4467z940dz6b27765c296b

Investigating the molecular signature of reactive astrocytes mediated by the JAK2- STAT3 pathway using different omics : transcriptomics and proteomics insights

Riquelme‐Perez, M. (2023) · theses.fr (ABES) · doi:10.70675/72aad0d8z36a8z4a7azb1eaze65fa79463da

Étude de la vascularisation intra-nerveuse dans les neuropathies périphériques induites par l'oxaliplatine : vers de nouvelles pistes thérapeutiques

Durand, J. (2024) · doi:10.70675/5bc9c28bz2375z4c64z99dazf463bfa284dc

Huntington’s Disease as a Neuroglial Systems Disorder: Mechanisms, Network Propagation, and Therapeutic Opportunities

Pérez-Villavicencio, J., Villa-Robledo, O., Megchun-Vázquez, X., Uriarte-Jiménez, F., Rubio‐Osornio, M., & Serrano‐García, N. (2026) · Neuroglia · doi:10.3390/neuroglia7030023

Huntington’s disease vasculopathy is barrier-type-selective and arteriolar-dominant with spatially-coupled astrogliosis and reversible by S1pr1 stimulation

Kucharz, K., Soylu-Kucharz, R., Saint‐Pierre, M., Alpaugh, M., Qvist, F. L., Björkqvist, M., Skotte, N. H., Cicchetti, F., & Lauritzen, M. (2026) · Nature Communications · doi:10.1038/s41467-026-77474-4

Comparative analysis of regional blood–brain barrier permeability in humans and rodents: implications for functional specialization and aging

Mirloo, S., Kamintsky, L., Corte-Samuel, S., Muradov, J. H., Mansoor, S., Alhadeed, L., Ahmad, A. A., Shafiq, B., Talebanpour, A., Saar‐Ashkenazy, R., et al. (2026) · Fluids and Barriers of the CNS · doi:10.1186/s12987-026-00881-8

Cerebrovascular and blood–brain barrier impairments in Huntington's disease: Potential implications for its pathophysiology

Drouin‐Ouellet, J., Sawiak, S. J., Cisbani, G., Lagacé, M., Kuan, W., Saint‐Pierre, M., Dury, R. J., Alata, W., St‐Amour, I., Mason, S. L., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24406 · Cited by 288 · see citing works

Longitudinal alterations in brain perfusion and vascular reactivity in the zQ175DN mouse model of Huntington’s disease

Vasilkovska, T., Salajeghe, S., Vanreusel, V., Audekerke, J. V., Verschuuren, M., Hirschler, L., Warnking, J. M., Pintelon, I., Pustina, D., Cachope, R., et al. (2024) · Journal of Biomedical Science · doi:10.1186/s12929-024-01028-3 · Cited by 8 · see citing works

Neurovascular abnormalities in humans and mice with Huntington's disease

Lin, C.-Y., Hsu, Y.-H., Lin, M.-H., Yang, T.-H., Chen, H.-M., Chen, Y.-C., Hsiao, H.-Y., Chen, C.-C., Chern, Y., & Chang, C. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.08.019 · Cited by 98 · see citing works

Removal of some textile dyes with laccase from Anoxybacillus Gonensis (P39)

Yanmış, D., Bozoglu, C., Nadaroğlu, H., Adıgüzel, A., & Güllüce, M. (2013) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2013.05.058 · Cited by 2 · see citing works

Impaired Cerebrovascular Reactivity in Huntington’s Disease

Chan, S., Mercaldo, N. D., Kwong, K. K., Hersch, S. M., & Rosas, H. D. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.663898 · Cited by 18 · see citing works